Loading
A phase 2 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), fluorouracil (5-FU) and leucovorin (folinic acid) in pancreatic cancer, run by Changhai Hospital, not yet recruiting.
Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX is a phase 2, randomised interventional study registered as NCT06210360 by Changhai Hospital, with a registry enrolment figure of 134 participants, started 2024-02-01 and due to reach its primary completion in 2025-04-01. Interventions recorded: Irinotecan liposome injection; Oxaliplatin; 5-FU; LV. Conditions listed: Pancreatic Cancer. Primary outcome: 2-year Overall Survival Rate. Pancreatic eligibility wording from the registry: "Histologically or cytologically proven pancreatic ductal adenocarcinoma". No results are recorded here; the registry entry is the source.
Shares Liposomal irinotecan, Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU) and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Topoisomerase-I inhibitors (and ADC payloads) and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Topoisomerase-I inhibitors (and ADC payloads) and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.